経腸栄養製剤の世界市場：高分子製剤、単量体製剤、疾患特異的製剤...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.4.1 Key Data From Secondary Sources
2.4.2 Key Data From Primary Sources
2.4.3 Key Industry Insights From Primary Sources
2.4.4 Assumption for the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 39)
4.1 Market Overview
4.2 Asia-Pacific Market, By Application
4.3 Geographic Snapshot of the Market
4.4 North America to Dominate the Market During the Forecast Period
4.5 Market: Developing vs. Developed Countries

5 Market Overview (Page No. – 43)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Stage
5.2.2 By Product
5.2.3 By Application
5.2.4 By End User
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Rising Geriatric Population Across the Globe
5.3.1.2 High Prevalence of Chronic Diseases and Disorders
5.3.1.3 Increasing Healthcare Expenditure
5.3.1.4 Growing Number of Preterm Births
5.3.1.5 Increasing Demand for Homecare
5.3.2 Market Restraints
5.3.2.1 Complications Associated With Enteral Feeding
5.3.2.2 Patient Safety Risks and Occurrence of Feeding/Medication Errors Associated With Enteral Feeding Devices
5.3.3 Market Opportunities
5.3.3.1 Growth in Healthcare Expenditure of Emerging Economies
5.3.3.2 Increasing Demand for Personalized Medicine
5.3.4 Market Challenges
5.3.4.1 Insufficient Reimbursements

6 Industry Insights (Page No. – 54)
6.1 Introduction
6.2 Industry Trends
6.2.1 Shift From Parenteral to Enteral Nutrition
6.2.2 Microencapsulation
6.3 Strategic Benchmarking
6.3.1 Product Portfolio Analysis: Market
6.4 Regulatory and Reimbursement Scenario
6.4.1 Regulatory Analysis
6.4.2 Reimbursement Analysis

7 Global Enteral Feeding Formulas Market, By Stage (Page No. – 58)
7.1 Introduction
7.2 Adults
7.3 Pediatrics

8 Global Enteral Feeding Formulas Market, By Product (Page No. – 64)
8.1 Introduction
8.2 Standard Formulas
8.2.1 Polymeric Formulas
8.2.2 Monomeric Formulas
8.3 Disease-Specific Formulas
8.3.1 Diabetic Formulas
8.3.2 Renal Formulas
8.3.3 Hepatic Formulas
8.3.4 Pulmonary Formulas
8.3.5 Other Formulas

9 Global Enteral Feeding Formulas Market, By Application (Page No. – 78)
9.1 Introduction
9.2 Oncology
9.3 Gastroenterology
9.4 Neurology
9.5 Diabetes
9.6 Critical Care
9.7 Other Applications

10 Global Enteral Feeding Formulas Market, By End User (Page No. – 91)
10.1 Introduction
10.2 Hospitals
10.3 Long-Term Care Facilities
10.3.1 Home Care Agencies and Hospices
10.3.2 Nursing Homes
10.3.3 Assisted Living Facilities

11 Global Enteral Feeding Formulas Market, By Region (Page No. – 102)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World
11.5.1 Latin America
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 186)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 New Product Launches
12.3.2 Expansions
12.3.3 Partnerships, Agreements, and Collaborations
12.3.4 Acquisitions

13 Company Profiles (Page No. – 193)
13.1 Introduction
13.2 Abbott Laboratories
13.3 Nestlé S.A.
13.4 Danone S.A.
13.5 Fresenius Kabi AG
13.6 Mead Johnson Nutrition Company
13.7 B. Braun Melsungen AG
13.8 Hormel Foods Corporation
13.9 Meiji Holdings Co., Ltd.,
13.10 Victus, Inc.
13.11 Global Health Products, Inc.

*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 219)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Available Customizations
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Related Reports